The first evaluation for subclavian artery occlusive disease should always be a simple measurement of bilateral brachial artery blood pressures. A significant difference between the two ...

It also provides administrative sets; adhesion prevention products; inhaled anesthesia ... It also provides technologies for ...

Gilead Sciences, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending seladelpar for the ...